-+ 0.00%
-+ 0.00%
-+ 0.00%

ELVINIX: LICENSE DEAL WITH ZEALAND PHARMA GRANTING ELVINIX RIGHTS TO DEVELOP, COMMERCIALIZE ZEALAND'S GLP-1/GASTRIN DUAL-AGONIST PEPTIDE PORTFOLIO

Reuters·09/15/2026 11:01:53

Please log in to view news